Pharmaceutical Industry Information Portal

HomeNews

News

The launch of R&D centre at BratskChemSyntez LLC

The R&D centre is tasked to optimise its substance manufacturing process and develop new unique molecules. The complex has modern and high-precision equipment that allows...

EMA evaluating data on booster dose of COVID-19 vaccine Comirnaty

EMA has started evaluating an application for the use of a booster dose of Comirnaty to be given 6 months after the second dose...

Russian scientists developed intestinal soluble capsules

Crohn's disease and ulcerative colitis are severe chronic bowel diseases for which there are no effective drugs yet. The main approach in their therapy...

Grindeks invests 800 thousand euros in the creation of a multifunctional site

Joint-stock company “Grindeks” has invested 800 thousand euros in the site of production of active pharmaceutical ingredients (APIs) and installed new, state-of-the-art laboratories and...

The single-component Sputnik Light vaccine authorized in Armenia

The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) today announced the Russian single-component Sputnik Light vaccine against coronavirus has been approved by...

EpiVacCorona-N vaccine to be released for use in near future

The EpiVacCorona-N coronavirus vaccine will be released into civil circulation in the near future, Tatiana Nepomnyashchikh, a deputy head of the Vector State Research...
spot_img

Expert Articles

spot_img